Impax Investors' Drug Price-Fixing Suit Revived By 9th Circ.

By Lauren Berg (January 11, 2021, 10:43 PM EST) -- The Ninth Circuit partially revived a shareholder suit Monday alleging generic-drug maker Impax Laboratories Inc. participated in a price-fixing scheme that led to a dip in the company's stock price, finding that the investors sufficiently alleged the cause of some of their economic losses but missed the mark on others....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!